A comparison of gEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer’s disease

被引:0
|
作者
T. J. Müller
J. Thome
R. Chiaramonti
T. Dierks
K. Maurer
A. J. Fallgatter
L. Frölich
M. Scheubeck
W. K. Strik
机构
[1] University Hospital Würzburg,Department of Psychiatry
[2] University Hospital Florence,Department of Neurology II
[3] University Hospital Frankfurt,Department of Psychiatry
[4] University Hospital Würzburg,Department of Nuclear Medicine
关键词
Quantitative EEG; HMPAO-SPECT; Alzheimer’s disease; Mini-Mental State examination; Syndrom-Kurz test; Alpha-anteriorisation;
D O I
暂无
中图分类号
学科分类号
摘要
Electroencephalographical studies have disclosed correlations between topographical features of Fast Fourier Transformation maps and the severity of Alzheimer’s disease (DAT). The object of the present study was to explore the relations of HMPAO-SPECT and quantitative EEG (gEEG) with the severity of dementia. Twenty-three patients were included in the study. Spectral and topographical EEG parameters were compared with global and regional cerebral blood flow, and with psychometric measures of clinical serverity. None of the regions of interest of the SPECT scans were significantly correlated with clinical severity. Low values in delta- and theta-bands, however, were related to high scores on the Mini-Mental-State examination (P < 0.01), whereas the Syndrom-Kurz test correlated inversely with the power values in the alpha and beta band. The global decrease in cerebral blood flow (CBF) was associated with a shift on the topographical alpha-centroids in the posterior direction (P < 0.01). In previous studies correlations between CBF and clinical severity were weak, indicating a high interindividual variance, or interactions with concomitant vascular lesions. Whereas SPECT is a well-established tool for the diagnosis of dementia, the present study indicates qEEG as a potential marker for the staging of the cognitive decline in DAT.
引用
收藏
页码:259 / 263
页数:4
相关论文
共 50 条
  • [1] A comparison of qEEG and HMPAO-SPECT in relation to the clinical severity of Alzheimer's disease
    Muller, TJ
    Thome, J
    Chiaramonti, R
    Dierks, T
    Maurer, K
    Fallgatter, AJ
    Frolich, L
    Scheubeck, M
    Strik, WK
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1997, 247 (05) : 259 - 263
  • [2] Using SPM as a diagnostic help with HMPAO-SPECT in Alzheimer's disease
    Ebmeier, K
    Prohovnik, I
    Pupi, A
    Rodriguez, G
    Nobili, F
    Migneco, O
    Koulibali, M
    Herholz, K
    Scheidhauer, K
    Glabus, M
    [J]. NEUROIMAGE, 2001, 13 (06) : S1044 - S1044
  • [3] Decreased cerebral blood flow and prognosis of Alzheimer's disease: A multicenter HMPAO-SPECT study
    Tsunehiko Nishimura
    Kazuo Hashikawa
    Hidenao Fukuyama
    Takao Kubota
    Shin Kitamura
    Hiroshi Matsuda
    Haruo Hanyu
    Hidehiko Nabatame
    Naohiko Oku
    Hirotaka Tanabe
    Yasuo Kuwabara
    Seishi Jinnouchi
    Atsushi Kubo
    [J]. Annals of Nuclear Medicine, 2007, 21 : 15 - 23
  • [4] Automated analysis of HMPAO-SPECT of Alzheimer patients.
    Radau, PE
    Slomka, PJ
    Julin, P
    Svensson, L
    Wahlund, LO
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 107P - 107P
  • [5] Decreased cerebral blood flow and prognosis of Alzheimer's disease: A multicenter HMPAO-SPECT study
    Nishimura, Tsunehiko
    Hashikawa, Kazuo
    Fukuyama, Hidenao
    Kubota, Takao
    Kitamura, Shin
    Matsuda, Hiroshi
    Hanyu, Haruo
    Nabatame, Hidehiko
    Oku, Naohiko
    Tanabe, Hirotaka
    Kuwabara, Yasuo
    Jinnouchi, Seishi
    Kubo, Atsushi
    [J]. ANNALS OF NUCLEAR MEDICINE, 2007, 21 (01) : 15 - 23
  • [6] Automated segmentation and registration technique for HMPAO-SPECT imaging of Alzheimer's patients
    Radau, PE
    Slomka, PJ
    Julin, P
    Svensson, L
    Wahlund, LO
    [J]. MEDICAL IMAGING 2000: IMAGE PROCESSING, PTS 1 AND 2, 2000, 3979 : 372 - 384
  • [7] CLINICAL-SIGNIFICANCE OF THE INCREASED UPTAKE OF HMPAO-SPECT
    ALEXANDROV, AV
    EHRLICH, LE
    BLADIN, CF
    SMURAWSKA, LT
    BLACK, SE
    NORRIS, JW
    [J]. STROKE, 1994, 25 (03) : 734 - 734
  • [8] Comparative studies in Alzheimer's disease: EEG-brain mapping, HMPAO-SPECT and psychometric tests.
    Mueller, TJ
    Strik, WK
    Thome, J
    Chiaramonti, R
    Dierks, T
    Froelich, L
    Maurer, K
    Scheubeck, M
    Hissnauer, G
    [J]. BRAIN TOPOGRAPHY, 1996, 8 (04) : 415 - 416
  • [9] TOPODIAGNOSIS IN CREUTZFELDT-JAKOB DISEASE BY HMPAO-SPECT
    HEYE, N
    FARAHATI, J
    HEINZ, A
    BUTTNER, T
    PRZUNTEK, H
    REINERS, C
    [J]. NUKLEARMEDIZIN, 1993, 32 (01) : 57 - 59
  • [10] Cerebral perfusion (HMPAO-SPECT) in Patients with Mild-cognitive-impairment and Alzheimer's Disease: A Semiquantitative and Automated Evaluation
    Samuraki, M.
    Matsunari, I.
    Chen, W.
    Yajima, K.
    Yanase, D.
    Fujikawa, A.
    Takeda, N.
    Nishimura, S.
    Matsuda, H.
    Yamada, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S184 - S184